Yüklüyor......
All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism
Oral anticoagulants used for the primary treatment of venous thromboembolism (VTE) include warfarin and the more recently introduced direct oral anticoagulants (DOACs), including rivaroxaban, apixaban, dabigatran, and edoxaban. Information on the comparative safety of these medications in routine cl...
Kaydedildi:
| Yayımlandı: | Thromb Haemost |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172009/ https://ncbi.nlm.nih.gov/pubmed/30103250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1668521 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|